HLFNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
HERBALIFE LTD.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$13.88−0.72 (-4.93%)
Close on Oct 19, 2026
- Market cap
- $1.45B
- P/E (TTM)
- 9.0
- Dividend yield
- –
HERBALIFE LTD. revenue by segment
By business segment
By product or service
By region
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary Reporting Segment [Member] | $4.95B | $4.86B | $4.76B | $4.68B | $4.64B | $4.66B | $4.70B | $4.69B | $4.71B | $4.74B | $4.74B | $4.71B | 95.2% | +6.6% |
| Others [Member] | $2.03B | $2.04B | $2.03B | $2.00B | $1.99B | $1.99B | $2.00B | $1.79B | $1.87B | $1.96B | $2.03B | $2.32B | 39.1% | +2.1% |
| India | $1.02B | $955.70M | $889.60M | $857.70M | $849.60M | $850.60M | $844.80M | $839.10M | $836.70M | $821.50M | $796.60M | $752.50M | 19.7% | +20.4% |
| United States | $1.00B | $1.00B | $1.01B | $1.01B | $1.01B | $1.02B | $1.03B | $1.03B | $1.05B | $1.07B | $1.10B | $1.12B | 19.2% | -0.4% |
| Mexico | $609.10M | $585.30M | $557.70M | $534.00M | $518.70M | $524.20M | $538.60M | $536.50M | $542.30M | $538.10M | $525.00M | $521.10M | 11.7% | +17.4% |
| Vietnam | $284.70M | $280.30M | $278.20M | $282.60M | $280.80M | $283.50M | $283.70M | – | – | – | – | – | 5.5% | +1.4% |
| China | $251.70M | $271.30M | $279.10M | $282.00M | $285.50M | $287.20M | $297.60M | $313.90M | $328.60M | $334.90M | $327.40M | $316.30M | 4.8% | -11.8% |
From the segment and revenue-disaggregation notes of Herbalife's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.